CliffBio
small molecule

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Active ingredientBISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Strength2.5MG;6.25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2021
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.